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Standard culture of human induced pluripotent stem cells (hiPSCs) requires basic Fibroblast Growth Factor
(bFGF) tomaintain the pluripotent state, whereas hiPSCmore closely resemble epiblast stem cells than true
naı¨ve state ES which requires LIF to maintain pluripotency. Here we show that chemokine (C-C motif)
ligand 2 (CCL2) enhances the expression of pluripotent marker genes through the phosphorylation of the
signal transducer and activator of transcription 3 (STAT3) protein. Moreover, comparison of
transcriptomes between hiPSCs cultured with CCL2 versus with bFGF, we found that CCL2 activates
hypoxia related genes, suggesting that CCL2 enhanced pluripotency by inducing a hypoxic-like response.
Further, we show that hiPSCs cultured with CCL2 can differentiate at a higher efficiency than culturing with
just bFGF andwe showCCL2 can be used in feeder-free conditions in the absence of LIF. Taken together, our
finding indicates the novel functions of CCL2 in enhancing its pluripotency in hiPSCs.
I
nduced pluripotent stem cell (iPSCs) reprogramming holds great promise in providing donor matched cells
for regenerative medicine and for generating cell and animal models for studying specific genetic diseases. The
technology allows us to derive pluripotent stem cells from mature and specialized cells, which can then be
differentiated into various cell types1–3. Providing fully competent iPSCs for differentiation into any desired target
cell is required for clinical usage, therefore, it is critically important to establish and maintain high quality iPSCs.
Recently it was discovered that in rodents, pluripotent stem cells may be classified into two distinct states: the
ES-like or ‘‘naive’’ pluripotent state and the post implantation epiblast-like (EpiSC-like) or the ‘‘primed’’ state of
pluripotency4. Inmouse, ES-like pluripotent stem cells are distinguished from other pluripotent stem cells by self-
renewal in response to LIF signaling andMEK/GSK3 inhibition (LIF/2i conditions) and by two active X chromo-
somes in female cells5–8. Epiblast stem cells (EpiSCs) depend on the FGF4 signaling pathway and are independent
of LIF signaling. EpiSCs can differentiate in vitro into the three germ layers similar to ES cells, and are therefore
considered as pluripotent, however, EpiSCs largely do not contribute to chimera formation and are thus not
considered totipotent9.
Human iPSCs and embryonic stem cells (ESCs) are considered to exhibit the characteristics of EpiSCs like
cells7,9. When comparing human and mouse ESCs/iPSCs, there are differences in cell morphology, lower effi-
ciency of attachment of the cells after the passaging, X chromosome inactivation (XCI) and different require-
ments are necessary for cell culture maintenance (FGF/ACTIVIN in human versus LIF/STAT in mouse). Hanna
et al., have recently published the first evidence for a novel ‘‘naı¨ve’’ pluripotent state in humans that corresponds
and shares defining features with mouse naı¨ve ESCs10 although the human naı¨ve state can be maintained only for
limited passages before the cells differentiate10. These differences place human ESCs/iPSCs to a state closer to the
mouse EpiSCs rather than to mouse ESCs10, which can affect the efficiency of differentiation into desired target
cells11.
Somatic stem cells reside in niches, and environmental changes, such as temperature, extracellular matrix
proteins, stromal cell contacts, and oxygen tension, have a great influence on stem cell function and differenti-
ation. For example, Tomoda et al. have recently reported that culturing conditions can influence the X chro-
mosome inactivation status in hiPSC12,13. X-chromosome reactivation (XaXa), a characteristic of naı¨ve
pluripotent state cells, rarely occurs during the reprogramming of human female somatic cells to induced
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pluripotent stem cells. Furthermore, mammalian embryonic epi-
blasts reside in a physiologically hypoxic environment, and culturing
ESCs in a hypoxic environment is known to prevent differentiation
of human ESCs and enhance generation of human and mouse iPS
colonies14–16. The importance of hypoxia is further highlighted by a
study by Lengner et al., where they showed that hypoxia drives
human embryonic stem cells into a pre-X inactivation state by the
repression of XIST genes17. In addition, Mathieu et al. have shown
that hypoxia can drive committed cells back to a stem cell-like state16.
The cultivation of hiPSCs commonly relies on the use of feeder
cells from mouse embryonic fibroblasts (MEF), which provide a
milieu of factors into the media to help maintain their undifferenti-
ated state. This dependence on feeder cells increases the potential for
xeno-contamination, as such they are not suitable for clinical use18.
In order to bring hiPSCs onto the clinical stage, we sought to identify
new culturing conditions that would support hiPSCs in a higher
pluripotent state and allow for feeder-free culture on matrices such
as laminin511/52119. Human iPSCs secrete laminin 511/521, one of
the most important functional basement membrane components,
and they can be maintained on human laminin 511 and 521 in
defined culture conditions. However, large-scale production of puri-
fied or recombinant laminin 511 and 521 is difficult and expensive.
Previously, we demonstrated that a chemokine, known as Ccl2,
enhanced the pluripotency of mouse iPSCs/ESCs by up-regulating
Klf4,Nanog and Tbx3 via the activation of the LIF-STAT3 pathway20.
In this current study we extended our work onCcl2 andmouse iPSCs
to human iPSCs. Here we report the conserved role of CCL2 in
enhancing the pluripotency of human iPSCs. We demonstrate the
up-regulation of pluripotent markers KLF4, NANOG, ZFP42 and
DPPA3 via CCL2. We performed Cap Analysis Gene Expression
(CAGE), a transcriptome profiling technique, on libraries cultured
with and without CCL2 and observed a consistent up-regulation of
hypoxia related genes, suggesting that CCL2 induces a hypoxic-like
response in hiPSCs. Lastly, we demonstrate that CCL2 can support
hiPSCs cultured together with LIF in the absence of feeder cells and
bFGF. These data demonstrate that CCL2 is able to influence plur-
ipotency and improves the culturing of hiPSCs.
Results
CCL2 enhances expression of pluripotent genes in hiPSCs
possibly through JAK/STAT3 pathway. Human ESCs derived
from blastocysts and human iPSCs are usually cultured in bFGF-
containing medium, and LIF alone is insufficient to maintain
pluripotency21. The maintenance of pluripotency in human iPSCs
requires the TGFbeta/activin/nodal signaling pathway22 and not the
LIF pathway, whereasmouse iPSCs/ESCs depend on the JAK/STAT3
signaling pathway (Fig. 1a). To observe the effect of CCL2 on human
iPSCs (hiPSCs), we compared more than 20 passages on feeder cells
hiPSCs cultured with CCL2 (CCL2_hiPSCs) with hiPSCs cultured in
standard bFGF conditions (bFGF_hiPSCs).
We have previously demonstrated that culturing mouse iPSCs
with Ccl2 and LIF enhanced the expression of the pluripotency mar-
ker genes Klf4, Tbx3, and Nanog via a CCR2 and phosphorylated
STAT3 dependent pathway20. We examined the expression level of
key transcription factors of human iPSCs cultured on bFGF and
CCL2. Quantitative RT-PCR showed higher expression of
NANOG, KLF4, ZFP42 and DPPA3 in CCL2 treated hiPSCs com-
pared to those cultured with bFGF (Fig. 1b). The up-regulation of
these and other pluripotent marker genes was also confirmed among
multiple human iPS cell lines although the level of up-regulation
varied between lines (Supplementary Fig. 1S).
Previously inmouse, we failed to see an up-regulation ofZfp42 and
Dppa3with Ccl2, however, in human iPSCs we observed a significant
up-regulation under CCL2 culturing conditions. ZFP42 is involved
in the reprogramming of X-chromosome inactivation during the
acquisition of pluripotency, and DPPA3 and KLF4 are known to be
expressed at higher levels inmouse ES cells when compared tomouse
EpiSCs10. In addition, we examined whether bFGF is necessary for
the activation of down-stream transcription factors in hiPSCs cul-
tured with CCL2.When tested in combination, hiPSCs cultured with
CCL2 but without bFGF showed significantly higher expression of
pluripotent marker genes compared to hiPSCs cultured with bFGF
with CCL2 (Fig. 1c).
As we have previously demonstrated inmouse that CCL2 activates
the JAK/STAT3 pathway, we examined the effect of CCL2 in human
iPSCs. Examining the JAK/STAT3, AKT and PI3K pathways in
hiPSC cultured with CCL2 on feeder cells by immunoblotting, we
observed a 7-fold increase in phospho-Stat3 levels in CCL2_hiPSCs
compared to bFGF_hiPSCs (Fig. 1d). Phosphorylation of STAT3 in
hiPSCs cultured with bFGF was barely observed. In addition, we
observed repression of SMAD4 expression which is a gene activated
by TGFb/ACTIVIN/Nodal and bFGF signaling pathways was
observed when CCL2 and/or LIF are cultured with or without
bFGF (Fig. 1e). This is of interest as it has been shown that over-
activation of JAK/STAT3 is sufficient to efficiently induce the con-
version of EpiSCs into naive pluripotent cells in mouse23, and thus
may be a key factor in pushing hiPSCs towards a higher pluripotent
state.
Transcriptome analysis reveals that CCL2 enhances hypoxia
related genes. To further elucidate the downstream effects of
CCL2, we performed Cap Analysis Gene Expression (CAGE) on
RNA extracted from hiPSCs cultured with bFGF and hiPSCs
cultured with CCL2 (Supplementary Table S1). Briefly, CAGE
captures the 59 end of RNA molecules as a short tag24 and the
number of sequenced tags directly reflects the expression level of
RNA molecules. CAGE reads are clustered into CAGE tag clusters
(Supplementary Table S2), which usually lie at the 59 end of
annotated gene models, thus associating tag clusters to genes
(Fig. 2a). Using edgeR, a Bioconductor package for performing
differential expression analysis on digital gene expression data25,
we identified 219 and 119 genes (Supplementary Table S3)
significantly up and down-regulated in cells cultured with CCL2,
respectively (Fig. 2b). We examined enriched gene ontology (GO)
terms for the up-regulated genes (Supplementary Table S4) and
observed GO terms associated with transcription factor activity,
development, and board organismal terms (Fig. 2c). Enriched gene
ontology terms for down-regulated genes (Supplementary Table S5)
included a large range of GO terms associated with lipoproteins and
lipids, metabolic processes and response to stimulus (Fig. 2d),
suggesting an adjustment in the metabolism of the cells.
One of the most significantly up-regulated gene (FDR 5
2.106 e209) was endothelial PAS domain protein1 (EPAS1), which
is also known as hypoxia-inducible factor alpha 2. This gene is a
known transcription factor involved in the induction of oxygen regu-
lated genes. On the contrary, the most significantly down-regulated
gene (FDR5 1.522625 e266) was alpha-fetoprotein (AFP), which is a
major plasma protein produced by the yolk sac and liver during fetal
life and is repressed under hypoxic conditions in human hepatoma
cells26. Together with the observation of the enriched GO terms,
response to oxygen-containing compound and cellular response to
oxygen-containing compound (Fig. 2d), we wanted to ascertain
whether CCL2 was inducing a hypoxic response.
It has been reported that hypoxia enhances the generation and
maintenance of induced pluripotent stem cells14–16, which perhaps
was one way CCL2 enhanced pluripotency. We obtained a list of 15
GO terms related to hypoxia and extracted 225 Entrez genes assoc-
iated with these GO terms (Supplementary Table S6). We ranked the
expression of these genes by the false discovery rate obtained from
the differential expression analysis performed on the two conditions.
Examining the top 17 genes, we found that amajority of genes related
to hypoxia were up-regulated when cultured with CCL2 (Fig. 2e).
www.nature.com/scientificreports
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While the first 6 genes, were statistically significant (FDR, 0.05), the
remaining 11 were not due to the variance among the replicates. As
such, we performed qRT-PCR and validated most of the expression
patterns between the two conditions (Supplementary Fig. S3). We
observed the up-regulation of CCL2, which has been reported to be
up-regulated under hypoxic conditions27 and reported to induce the
JAK/STAT pathway via the phosphorylation of STAT328, corrob-
orating with observations above.
Lastly, we compared our list of 219 up-regulated genes to a list of
hypoxia-induced genes (see methods) measured using a technology
very similar to CAGE called oligo-capping29,30, and found a signifi-
cant overlap of 45 genes (exact binomial test, p-value 5 0.016,
Supplementary Table S7). Overall our CAGE analysis suggests that
CCL2 triggered a transcriptional up-regulation of genes related to
hypoxia.
CCL2 drives human iPSCs into higher pluripotent state. One of
the signatures of blastocyst-like (ground) or naı¨ve state iPSCs is the
phosphorylation of STAT331, which was observed with the addition
of CCL2. Naı¨ve state hESCs, which rely on LIF signaling, also
displayed high levels of pStat310. Another signature of naı¨ve state is
X chromosome reactivation and it has been reported that human
iPSCs cultured under hypoxia show decreasedXIST expression17.We
quantified the expression of XIST and other X-linked genes by qRT-
PCR to examine the X chromosome status.
We observed significantly lower XIST expression in our CCL2
cultured hiPSCs compared to the bFGF-cultured cells (Fig. 3a) and
conversely, the antisense regulator of theXIST gene,TSIX showed 2.7
fold more expression in CCL2 treated conditions (Fig. 3a). In addi-
tion, we compared expression levels of 11 X-linked genes, reported to
undergo X chromosome inactivation by qRT-PCR with 10 out of 11
genes still showing modestly higher expression in CCL2 treated
hiPSCs (Fig. 3b).
These observations are in agreement with our observation in
Fig. 1b that ZFP42 is up-regulated. ZFP42 is required for efficient
elongation of TSIX and binds theDXPas34 enhancer within theTSIX
promoter. ZFP42 is known to be involved in ES cell self-renewal;
mouse ZFP42 is expressed in ES cells but is more heterogeneous in
EpiSC7.
In addition, several cell adhesion genes were up-regulated in
CCL2_hiPSCs including HAPLN1, MEGF10, COL12, and SDK2 in
CCL2_hiPSCs confirmed by qRT-PCR (Fig. 3c). Cell adhesion is
essential for embryonic development.We observed that higher num-
ber of colonies attached with hiPSCs cultured with CCL2 after pas-
saging when compared with bFGF. To quantify this observation, we
tallied colony numbers formed after 48 hours of passaging the same
Figure 1 | CCL2 enhances the expression of pluripotent genes via the phosphorylation of STAT3. (a): Signal pathway diagrams formouse ES/iPSCs and
human ES/iPSCs. (b): Quantitative RT-PCR of four key pluripotent genes in human iPSC cultured with bFGF (white bars) and with CCL2 (black bars).
Asterisks (*) denote significant p-values (Student’s t-test indicate, p-value , 0.05) and error bars denote standard deviations n 5 3. (c): Quantitative
RT-PCR for pluripotent marker genes on human iPSCs cultured with bFGF, CCL2 without bFGF and without bFGF and LIF. Asterisks (*) denote
significant p-values (Student’s t-test indicate, p-value , 0.05) and error bars indicate standard deviations for n 5 3. All primer sequences used in this
study are listed in Supplementary Table S8. (d): Immuno-blots of whole cell extracts from CCL2 or bFGF cultured human iPSCs were subjected to
immuno-blotting against antibodies for STAT3, phosphorylated STAT3, and GAPDH(left). Ratio of phosphorylated/total STAT3 estimated from the
immune-blots. Full length gels and blots are included in the supplementary information (Supplementary Fig. S2). P-values using Student’s t-test indicate
a highly significant difference (p-value, 0.01, n5 3) in STAT3 phosphorylation levels between bFGF andCCL2 conditions (right). (e): Quantitative RT-
PCR for Smad4 on human iPSCs cultured on feeder cells with adding either bFGF or CCL2 together with and without LIF. Error bars indicate standard
deviations for n 5 3.
www.nature.com/scientificreports
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Figure 2 | CapAnalysis Gene Expression reveals the up-regulation of hypoxia related genes and the down-regulation of genes associatedwith lipids and
lipoproteins. (a): A genome browser representation of CAGE reads from 5 different librariesmappingmainly to the 59 end of the EPAS1 gene. The red line
at the chromosome ideogram shows the current position and the scale displays the chromosome coordinates. ACAGE tag cluster is formed by aggregating
CAGE reads that lie in close proximity to each other. (b): MA plot showing the expression differences between bFGF and CCL2 CAGE libraries. On the x-
axis is the expression strength of a gene (on log2 scale) and on the y-axis is the fold change between the two conditions. A positive fold change indicates an
up-regulated gene in the CCL2 library and a negative fold change indicates down-regulation. Red dots indicate genes that are differentially expressed
between the two conditions with statistical significance. Genes related to lipid metabolism are down-regulated and genes related to cell adhesion and
hypoxia are up-regulated. The black lines indicate a fold change of1/2 2. (c and d): Enriched gene ontology terms are displayed as TreeMaps, where each
rectangle is a single cluster representative of closely related gene ontology (GO) terms. These representatives are further grouped into ‘‘superclusters’’ of
loosely related terms and have the same arbitrarily chosen color. (c) The list of GO terms over-represented in the list of up-regulated genes and (d) the list
of GO terms over-represented in the list of down-regulated genes in the CCL2 libraries. (e): Heatmap showing the expression strength of 17 hypoxia
related genes ranked by the p-value and subsequent false discovery rate calculated by the differential gene expression analysis. Each row shows the
normalized expression pattern (Z-Score) for that particular gene in the 2 bFGF and 3 CCL2 CAGE libraries.
www.nature.com/scientificreports
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number of hiPSCs cultured with bFGF and CCL2. In comparison
with cells cultured in the standard bFGF condition, hiPSCs cultured
with CCL2 attached better, had a higher cell survival rate and had
double the number of colonies at 48 hours (Data not shown). This
result can be explained by up-regulation of a significant numbers of
cell adhesion molecules.
Human iPSCs culturedwith CCL2 enhance differentiation ability.
We next examined the relative differentiation ability of CCL2_
hiPSCs and bFGF_hiPSCs. Spontaneous differentiation was used
to compare the two conditions: First, embryoid bodies (EBs) were
formed by using HEMA-coated dishes with EB formation medium
for 10 days, then EB were plated onto the gelatin-coated dishes and
Figure 3 | CCL2 reactivates X chromosome and enhances differentiation ability. (a): Quantitative RT-PCR of XIST and TSIX genes in human iPSC
cultured with bFGF (white bars) and with CCL2 (black bars). Asterisks (*) denote significant p-values (Student’s t-test p-value , 0.05) and error bars
denote standard deviations for n5 3. (b): Quantitative RT-PCR on additional X-linked genes related to X chromosome inactivation on bFGF_hiPSCs
and CCL2_hiPSCs. Asterisks (*) denote significant p-values (Student’s t-test p-value , 0.05) and error bars indicate standard deviations for n 5 3.
(c): Quantitative RT-PCR on human iPSC cultured with bFGF (white bars) and with CCL2 (black bars) for a panel of genes related to cell adhesion.
Asterisks (*) denote significant p-values (Student’s t-test p-value, 0.05) and error bars indicate standard deviations for n5 3. (d): The number of EBs
formed from same cell numbers of human iPSC cultured with bFGF (white bars) and with CCL2 (black bars). Asterisks (*) denote significant p-values
(Student’s t-test p-value , 0.05) and error bars indicate standard deviations for n 5 3. (d): Immunostaining and flow cytometry analysis with a
cardiomyocyte marker, Desmin (i), and a neuronal marker, Nestin (ii) and on spontaneously differentiated embryoid bodies derived from iPSC cultured
with bFGF andwith CCL2. The red color represents bothDesmin andNestin and blue represents nuclei staining. The lower panels show FACS analysis on
Desmin positive cells and Nestin positive cells of human iPSCs cultured with bFGF and with CCL2. Plotted graphs for replicate data of FACS analysis are
shown in Supplementary Figure S4.
www.nature.com/scientificreports
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medium was changed every other day for 14 days. CCL2 treated
hiPSCs formed more EBs than the hiPSCs cultured with bFGF
(Fig. 3d). The differentiated cells were then stained with the
cardiomyocyte marker, Desmin and the neuronal marker, Nestin.
FACS analysis showed that spontaneous differentiation of
CCL2_hiPSCs resulted in significantly more Desmin positive and
Nestin positive cells compared to those from the bFGF_hiPSCs
(Fig. 3d). These results suggest CCL2 treated hiPSCs are more
competent to differentiate into different lineages.
Human iPSCs cultured on CCL2 protein bead coated dishes can
maintain their pluripotency without feeder-cells. Since hiPSCs
cultured with CCL2 on feeder cells showed higher pluripotency
with higher adhesion, we tested whether CCL2 allows hiPSCs to
culture in feeder-free condition.
Traditionally, human iPSCs/ESCs require feeder cells for main-
taining pluripotency and proliferation. Using feeder cells reduces the
clinical potential of hiPSCs due to batch-to-batch variation in the
feeders and time-consuming preparation processes. To address this,
several feeder-free culture methods have been developed32,33 which
typically require matrigel (or other ECM component) coated dishes.
Testing various strategies for feeder free culture with CCL2 we
report that human iPSCs can be cultured on gelatin-coated dishes
by adding CCL2 and LIF into the medium. 24 hours after passaging
the cells onto feeder-free gelatin-coated dishes, hiPSCs cultured in
the presence of CCL2 and LIF attach to the plate while control cells
passaged into media containing bFGF do not. After 6 days of cultur-
ing, cells cultured with CCL2 and LIF showed significant prolifera-
tion (data not shown). In order to make feeder-free condition more
efficient and easier, we made CCL2 protein beads34, to provide a
sustained release of CCL2, similar to commercially available LIF
protein beads (Fig. 4a). H1 tagged CCL2 can be immobilized on virus
derived polyhedral. This can be used in conjunction with gelatin-
coated dishes to release CCL2 constantly for two weeks without the
need for daily medium change. We find that the combination of LIF
and CCL2 protein beads could support the proliferation of human
iPSCs without feeder cells (Fig. 4b).
Immunostaining with the pluripotent markers; Tra1-60 and
SSEA4, confirmed that the resulting colonies were still iPSCs
(Fig. 4b). In addition qRT-PCR confirmed CCL2 cultured feeder-
free hiPSCs express equivalent or higher levels of pluripotency genes
compared to bFGF cultured feeder dependent hiPSCs (Fig. 4c).
Finally, we examined whether LIF was necessary tomaintain plur-
ipotency in the feeder-free condition. Culturing hiPS with the immo-
bilized CCL2 beads only showed attachment of colonies but the
colonies were more differentiated (Fig. 4b), indicating a small
amount of LIF is still required to keep the pluripotency.
Discussion
Our previous work on mouse induced pluripotent stem cells
(miPSCs) identified Ccl2 as an inducer of the key transcription factor
genes for pluripotency, Klf4, Nanog, Sox2, and Tbx3, via the activa-
tion of the Stat3-pathway. Furthermore, it has been demonstrated
that Ccl2 can increase the efficiency of miPSCs generation from
mouse fibroblasts by roughly 12 fold35. In the current study, we
showed that CCL2 also promotes pluripotency of human iPSCs
and importantly appears to push them into a stabler state by activ-
ating STAT3 pathway. We have shown that CCL2 treated human
iPSCs show a higher colony attachment, up-regulate key markers of
pluripotency, differentiate at higher efficiency and show indication of
X chromosome reactivation.
The transcriptome profiling of hiPSCs cultured on CCL2 versus
bFGF suggested that CCL2 is able to induce a hypoxic response.
We found a significant overlap with our list of up-regulated genes
by CCL2 with a list of genes up-regulated in a colon cancer cell line
(DLD-1) cultured under hypoxic conditions30. In addition to this,
we examined the expression of a panel of genes associated to hypoxia
and found an overall up-regulation of these genes (Fig. 2e), which we
verified by qRT-PCR (Supplementary Fig. S3). In particular, the
endothelial PAS domain-containing protein 1 (EPAS1), also known
as hypoxia-inducible factor 2 alpha (HIF2A), was one of the most
statistically significant up-regulated genes in response to CCL2.
HIF2A works in tandem with HIF1A as a transcription factor and
along with hypoxic conditions, is required for the normal develop-
ment of the heart36. Corroborating with this, was the observation of a
large enrichment of gene ontology (GO) terms involved with heart
development for genes up-regulated by CCL2 (Supplementary Table
S4). On the contrary, we observed a large enrichment of GO terms
associated with cholesterol and lipid metabolism (Supplementary
Table S5) with genes down-regulated with CCL2. The down-regu-
lation of genes related to metabolism may promote the reduction of
oxygen consumption and it has been reported that hypoxia sup-
presses cholesterol synthesis37.
It also has been reported that CCL2 is directly up-regulated by
hypoxia-induced transcription27 and CCL2 is one of only two che-
mokines under the direct transcriptional control of HIF-1 regu-
lation38. Thus, the induction of HIF2A by CCL2 may activate a
hypoxic response in the hiPSCs. The enhancement in pluripotency
and differentiation ability by CCL2 may be explained by the obser-
vation that hypoxia enhances the generation of induced pluripotent
stem cells14. The role of hypoxia is well appreciated for the mainten-
ance of undifferentiated states of embryonic, hematopoietic,
mesenchymal, and neural stem cell phenotypes39. It is also known
that hypoxia is a hallmark of rapidly proliferating tumors and has
been suggested to be a characteristic of the embryonic and adult stem
cell niche39. Some of themolecular pathways that have been shown to
mediate these hypoxia-induced responses, such asHIF1A and Notch
signaling, appear to be active in both embryonic and neoplastic plur-
ipotent stem cells39. Furthermore, hypoxia also enhances formation
of embryoid bodies of human embryonic stem cells40, in line with our
observation that CCL2 treated hiPSCs formed more EBs than the
hiPSCs cultured with bFGF (Fig. 3d). Therefore a hypoxic condition
may trigger a similar signaling cascade and transcriptional program
in cells to promote stemness.
We have also demonstrated the conserved role of CCL2 in activ-
ating the STAT3 pathway in hiPSCs. Recently, it was found that the
activation of JAK/STAT3 is a limiting component for the induction of
naı¨ve pluripotency and can promote reprogramming EpiSCs to naı¨ve
pluripotency23,31. Another key characteristic of naı¨ve pluripotent state
cells is X-chromosome reactivation (XaXa). The XIST non-coding
RNA is primarily involved in X-chromosome inactivation and we
found that hiPSCs cultured with CCL2 showed a significant reduction
in the XIST expression compared to hiPSCs cultured with bFGF
(Fig. 3a). The TSIX antisense gene, which acts in cis to repress the
transcription ofXISTwas also found to be significantly over-expressed
in CCL2 hiPSCs (Fig. 3a). Together with STAT3 activation and XaXa
status, CCL2 may push hiPSCs into a much more naı¨ve state.
Our initial work on miPSCs cultured on feeder cells and in feeder-
free (LIF-treated) conditions identified Ccl2 as significantly over-
expressed in miPSCs cultured on feeder cells. Continuing this work
on hiPSCs has revealed the same activation of the STAT3-pathway
and the induction of key transcription factor genes for pluripotency.
The higher pluripotency state of hiPSCs cultured with CCL2 directly
resulted in a higher number of colony attachment (Data not shown)
and spontaneous differentiation ability (Fig. 3d, e). More impor-
tantly, we could culture human iPSCs without the use of feeder cells
but by coating the culture dish with gelatin solution on protein beads
that constantly secrete CCL2 (Fig. 4a). One of the risks associated
with using feeder cells to culture hiPSCs is the cross contamination
with viruses and other unwanted material. Thus the ability to culture
hiPSCs in a feeder-free environment has important implications for
therapeutic and research use.
www.nature.com/scientificreports
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Methods
Cell culturing. The human iPSC line iPS-201B-7 was purchased from RIKEN BRC.
Additional cell lines, hi25-4 (derived from human cord blood), hi76-2 (derived from
T cells), hi6 (derived from fibroblast) were kindly distributed by Dr.Koseki’s
laboratory in RIKEN Center for Integrative Medical Sciences.
Cells were cultured on mitomycin C (Sigma Aldrich) treated SNL76/7 cells
(ECACC, Porton Down, UK) in the Primate pluripotent stem cells media from
ReproCell (RCHEMD 001) containing 4 ng/ml basic Fibro Growth Factor (bFGF).
The cells were passaged in small clumps after treatment to remove feeder cells with
CTK solution, containing 0.025% trypsin, 0.1 mM collagenase IV, 0.1 mM CaCl2
and 20% Knockout serum replacement (KSR) (Invitrogen, Carlsbad, CA) every 3–5
Figure 4 | Feeder-free culturing of human iPSCs with CCL2 and LIF maintains pluripotency. (a): Diagram of protein beads: Schematic representation
of the preparation of CCL2 polyhedra. The immobilization signal derived from the VP3 region of the Bombyx mori cytoplasmic polyhedrosis virus
(BmCPV) was introduced at the C terminus of CCL2. The fusion protein is then co-expressed with BmCPV polyhedrin and incorporated into the
resulting polyhedral, which is coated on a dish together with gelatin solution. (b): Fluorescence images of immunostained human iPSCs cultured onCCL2
and LIF protein beads coated dish: Cells stained with TRA1-60 (green) (i) and SSEA4 (red) (ii). The bright field image of cells cultured on CCL2 protein
beads only, LIF beads only, and Gelatin solution only showed that the cells were unable to attach or failed tomaintain pluripotency (iii). (c): Quantitative
RT-PCR was performed on a range of pluripotency genes on bFGF_hiPSCs with feeder cells (black bars) and CCL2_iPSCs cultured without feeder cells
(white bars).
www.nature.com/scientificreports
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days. Recombinant CCL2 (WAKO, Osaka, Japan) was added into culture medium
with concentration of 10 ng/ml for culturing of human iPS cells. CCL2 was added
into the medium everyday when the medium was changed.
Quantitative RT-PCR. RNAs for quantitative real time-polymerase chain reaction
(qRT-PCR) were extracted from cells after removing feeder cells with CTK solution.
Reverse transcription for total RNAwas performed using the PrimeScript RT-PCR kit
(TAKARA BIO, Otsu, Shiga, Japan) and quantitative PCR (qPCR) was done in 10 ve
reaction mixtures with SYBR Premix EX Taq (TAKARA BIO) on an ABI 7500 Fast
RT-PCR system (Applied BioSystems, Calrsbad, CA). The thermal cycling consisted
of 40 cycles of 94uC for 5 seconds and 62.5uC for 20 seconds. The relative amount of
each target gene mRNA in each sample was calculated by normalization to
glyceraldehyde 3-phosphate dehydrogenease (GAPDH) mRNA using the 2-DDCT
method41.
The sequences of qRT-PCR primers used in this study are shown in Supplementary
Table S8.
Immuno-blotting. Cells were washed with phosphate-buffered saline and harvested
in 100 ml mammalian protein extraction reagent lysis buffer. Samples were
homogenized by passing through 26-gauge needles for 10 times and centrifuged at
13,000 rpm for 5minutes at 4uC to prepare the supernatant. The protein
concentration was determined by BCA protein assay (Thermo Scientific, Rockford,
IL). Total protein (10 mg) was subjected to 4%–12% Bis-Tris Novex Gel
electrophoresis and electroblotted onto nitrocellulose membranes. The membranes
were probed sequentially with anti-p-Stat3 (Cell Signaling Technology (CST),
Danvers, MA), anti-Stat3 (CST), anti-p-Akt (CST), anti-Akt (CST), p-Erk1/2
(Promega, Madison, WI), Erk1/2 (CST, #9102), and anti-GAPDH (Santa cruz
Biotechnology Inc. Santa Cruz, CA). Blots were incubated with horseradish
peroxidase-coupled anti-rabbit IgG or anti-mouse IgG and developed with ECL plus
(GE Healthcare). Membranes were stripped between probing by incubation for
15minutes at room temperature with 1X ReBlot Plus Strong Antibody Stripping
Solution (Millipore, Billerica, MA). Chemiluminescence was recorded with a Fuji
LAS-3000 luminescent image analyzer.
Differentiation of hiPSCs. For EB formation, FGF_iPSC cells were harvested by
treating with 1 mg/ml collagenase IV for one hour. The clumps of cells were then
transferred into 2-hudroxyethyl methacrylate (HEMA)-coated dishes for 6 days in
differentiation medium (knock-out DMEM containing 20% knockout serum
replacement, 2-b-mercaptoethanol, L-glutamine, penicillin-streptomycin, and non-
essential amino acids). EBs were plated onto gelatin coated tissue culture dishes at
very low density in DMEM medium with 20% animal serum. Medium was replaced
every two days. 7 days after, the EB was plated onto the gelatin-coated dish and
changed medium every other day for 14 days.
Flow cytometry. For detection of DESMIN and NESTIN, adherent cells were washed
twice in PBS and then incubated fro 20 minutes at 37uC in 0.5% trypsin. Cells were
dissociated by gentle pipetting and resuspended at approximately 0.1–1 3 105 cells
per milliliter in PBS 1 3% normal goat serum (NGS). Cells were incubated for 40
minutes at 4uC with fluorescein-conjugated antibody to DESMIN (Millipore) and
NESTIN (Millipore) or corresponding isotype control. Stained cells were analyzed for
surface marker expression using FACSCalibur (BD Biosciences, San Jose, CA).
Transcriptome analysis. 5 mg of pooled RNAs was isolated from hiPSCs cultured
with bFGF and hiPSCs cultured with CCL2. Cap Analysis Gene Expression (CAGE)
libraries were prepared and sequenced on the HeliScope Genetic Analysis System
(Helicos Biosciences) as previously described42. The raw sequencing data is available
at http://fantom.gsc.riken.jp/5/. Raw reads containing base-order addition artifacts
and other low quality reads were removed using the SMS filter program (Helicos
Biosciences). In addition, reads shorter than 20-nt and longer than 70-nt were
removed from further analysis. Reads were mapped to the human genome (hg19)
using Delve (T. Lassmann in preparation), a high-throughput short read sequence
alignment tool that can recognize sequencing biases or increased error rates in
homopolymer stretches. We analyzed 14,905,756 CAGE reads from 5 libraries that
could be mapped with a mapping quality of 10 or higher (Supplementary table S1).
All analyses were performed using R version 3.0.2, using the R Bioconductor
(version 2.13) packages CAGEr (1.4.1) for CAGE tag clustering, edgeR (3.4.0) for
differential expression, biomaRt (2.18.0) for obtaining Entrez gene models,
GenomicFeatures (1.14.2) and GenomicRanges (1.14.3) for genome annotation and
GOstats (2.28.0) for gene ontology (GO) enrichment. Enriched GO terms were
summarized using the web tool REViGO43. Tag clusters falling within1/2 200 bp of
the 59 end of Entrez Gene models were annotated as the gene it overlapped.
An applied oligo-capping method29, similar to CAGE, was used to observe gene
expression changes in a colon cancer cell line (DLD-1) cultured in normoxic and
hypoxic conditions30. Briefly, the method selectively replaces the cap structure of
mRNA with a synthetic oligo and oligo-cap cDNA libraries are massively sequenced.
Their analysis analyzed 13,140 genes and identified 2,690 hypoxia-induced RefSeq
genes (corresponding to 1,903 Entrez Genes) with at least two tag per million
expression and a fold change greater than 1.5. We overlapped their list of hypoxia-
induced Entrez Genes with our list and found an overlap of 45 genes. Using an exact
binomial test, (number of successes5 45, number of trials5 219, and probability of
success 1903/13140), the probability of the overlap was 0.01586.
We used the Benjamini-Hochberg procedure for controlling the false discovery
rate and p-values less than 0.05 were deemed as statistically significant for all analyses.
R analyses are publicly available at https://github.com/davetang/ccl2.
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